Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to determine the steady-state pharmacokinetics and urinary excretion of porfiromycin
and major metabolites in head and neck cancer and other cancer patients with solid tumors who
receive radiation therapy.